Nexavar as First Targeted Therapy in Patients With Advanced Renal Cell Carcinoma

Clinical trial NCT01508364 · COMPLETED

Trial details

NCT number: NCT01508364
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Carcinoma, Renal Cell

Start date: 2012-07-01
Primary completion: 2013-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.